Su et al. investigated the potential usefulness of TSPO PET with [11C]-(R)PK11195 to differentiate low-grade (LGGs) from high-grade gliomas (HGGs), also in the perspective of eventual TSPO-targeted therapies [21]. The gene discussed is TSPO; the disease is glioma.